Early data suggests an AI-developed drug could slow aging
Dr_Singularity · x · 2026-09-07
A brief repost of the Rentosertib story: the AI-assisted drug candidate, originally developed for a rare lung condition, also seems to reduce biological hallmarks of age, according to its maker Insilico Medicine.
More from Research
- scikit-learn 1.9 ships metric_at_thresholds to simplify optimal decision threshold search — GaelVaroquaux · 2026-09-08
- Astra agent inside Codex picks the same cancer sequencing variants a researcher would choose — iskander · 2026-09-08
- Enterprise agent evals need world-first design, not task-first, argues Shahules Anwar — Shahules786 · 2026-09-08
- Ineffable Labs adds six co-founders alongside ex-DeepMind's David Silver — giffmana · 2026-09-08
- Training a 9B model with GRPO to build low-poly Blender rooms: lessons learned — TheMoonMidas · 2026-09-08
- 2026 PNPL competition targets non-invasive speech decoding with MEG — pnpl · 2026-09-08